Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04314089
Title Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Edward Patz
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Advent Health Celebration Florida 34747 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Duke University Medical Center Durham North Carolina 27540 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field